Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07497256 | Decision Aid for Women Newly Diagnosed With Breast Cancer(BCT Aid) | not yet recruiting | N/A | 160 | Xiamen UniversityOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT07539753 | Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases | not yet recruiting | Phase 2 | 46 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Apr 30, 2026 |
| clinicaltrials |
| NCT07560124 | A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer | not yet recruiting | Phase 1 / Phase 2 | 286 | AkesoINDUSTRY | 1 | Apr 30, 2026 | clinicaltrials |
| NCT07555600 | Enumeration and Functional Analysis of Circulating Tumor Cells for Homologous Recombination: a Prospective Single-center Study on Advanced/Metastatic Solid Tumors(E-FACTOR) | not yet recruiting | N/A | 300 | Centre Leon BerardOTHER | 0 | Apr 29, 2026 | clinicaltrials |
| NCT07554781 | A Single-Center, Retrospective Study to Improve the Visibility of Breast Tissue Marker Clips in Breast Tissue and Axillary Lymph Nodes Using the Color Doppler Twinkling Artifact | not yet recruiting | — | 86 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Apr 28, 2026 | clinicaltrials |
| NCT07494448 | Phase Ib/II Study of Zanidatamab Plus Tucatinib and Chemotherapy in HER2-Positive Advanced Breast Cancer(JAZMINE) | not yet recruiting | Phase 1 / Phase 2 | 24 | MedSIROTHER | 0 | Apr 23, 2026 | clinicaltrials |
| NCT07544134 | Areola Preservation in NSM With Nipple Involvement(APRESERVE-1) | not yet recruiting | N/A | 40 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT07543107 | Verification of Range Accuracy and Correlation With Clinical Toxicity Using Offline PET/CT for Hypofractionated Proton Radiotherapy in Breast Cancer(OFFLINE-PET-PR) | not yet recruiting | — | 30 | Ruijin HospitalOTHER | 0 | Apr 21, 2026 | clinicaltrials |
| NCT07543250 | A Real-World Study of Inavolisib in Patients With HR-Positive/HER2-Negative, PIK3CA-Mutated Advanced Breast Cancer | not yet recruiting | — | 100 | xuliangOTHER | 0 | Apr 21, 2026 | clinicaltrials |
| NCT07015853 | ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation | not yet recruiting | Phase 2 | 34 | Stephen ShiaoOTHER | 1 | Apr 20, 2026 | clinicaltrials |
| NCT07539545 | The Comparison Between M-E-BCS and C-O-BCS.(MECO) | not yet recruiting | N/A | 1,366 | Du ZhengguiOTHER | 1 | Apr 20, 2026 | clinicaltrials |
| NCT07504770 | Surgical Glove Compression to Prevent Paclitaxel Neuropathy(Surgical Glove) | not yet recruiting | N/A | 84 | Necmettin Erbakan UniversityOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT07527806 | Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging | not yet recruiting | Phase 2 | 156 | Peking University Cancer Hospital & InstituteOTHER | 0 | Apr 17, 2026 | clinicaltrials |
| NCT07537712 | Proton vs Photon IMRT Toxicity in Breast Cancer(PPTOX-BC) | not yet recruiting | — | 750 | Ruijin HospitalOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT07425548 | Evaluation of Quality of Life After Facial Hyaluroic Acid Injections Following Treatment for Breast Cancer.(JOUVENCE) | not yet recruiting | N/A | 22 | Institut BergoniéOTHER | 0 | Apr 16, 2026 | clinicaltrials |
| NCT07533526 | Effects of Instrument-Assisted Constant-Speed Injection Versus Manual Injection on Pain From Large-Volume Subcutaneous Injection of Pertuzumab and Trastuzumab in Breast Cancer: A Randomized, Self-Controlled Study | not yet recruiting | N/A | 40 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT07532096 | Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast Cancer | not yet recruiting | N/A | 240 | Xijing HospitalOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT07527468 | HISMAR: Intraoperative Margin Assessment Using the Histolog® Scanner to Reduce Reoperation in Breast-Conserving Surgery(HISMAR) | not yet recruiting | N/A | 228 | Hôpital du ValaisOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT07527819 | Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)(FERTILE) | not yet recruiting | — | 75 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT07528898 | Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study. | not yet recruiting | Phase 2 | 100 | Hebei Medical University Fourth HospitalOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT02802423 | Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer. | not yet recruiting | Phase 1 / Phase 2 | 44 | BioLite, Inc.INDUSTRY | 0 | Apr 13, 2026 | clinicaltrials |
| NCT07516626 | Patient-Derived Organoids to Functionally Characterize Chemotherapy Resistance in Breast Cancer(BC-PDO) | not yet recruiting | — | 40 | Atlas UniversityOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT07523516 | Diagnostic Performance of 18F-FDG PET/CT in Detecting Distant Metastases in Breast Cancer | not yet recruiting | — | 97 | Assiut UniversityOTHER | 0 | Apr 13, 2026 | clinicaltrials |
| NCT07523789 | Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC | not yet recruiting | — | 201 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT07519200 | Sexual Health and Rehabilitation for Women With Metastatic Breast Cancer (SHARE-MC): An Educational Intervention(SHARE-MC) | not yet recruiting | N/A | 96 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 9, 2026 | clinicaltrials |
| NCT07509515 | QLC5513 Alone or in Combination With QL1706 in Previously Treated Advanced or Metastatic TNBC. | not yet recruiting | Phase 2 | 60 | Fudan UniversityOTHER | 0 | Apr 3, 2026 | clinicaltrials |
| NCT07502963 | Effectiveness of a Multimodal Outpatient Supervised Physical Activity Program to Improve Tolerance and Efficacy of Chemotherapy in Adults With Breast, Lung and Colon Cancer(PREDU) | not yet recruiting | N/A | 70 | University of Vic - Central University of CataloniaOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT07499089 | Together-Breast Cancer Support Platform(Together) | not yet recruiting | — | 24 | Cedars-Sinai Medical CenterOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT07499999 | Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer(BabyTEARS) | not yet recruiting | Phase 2 | 140 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT07500129 | Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer(ExoTSS-BC) | not yet recruiting | — | 60 | Atlas UniversityOTHER | 0 | Mar 30, 2026 | clinicaltrials |
| NCT06396754 | Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC(AIDOBE) | not yet recruiting | — | 50 | Institute of Cancer Research, United KingdomOTHER | 0 | Mar 27, 2026 | clinicaltrials |
| NCT07497191 | AMH Dynamic Changes to Predict Ovarian Reserve in Perimenopausal Breast Cancer | not yet recruiting | — | 300 | Shengjing HospitalOTHER | 0 | Mar 27, 2026 | clinicaltrials |
| NCT07219797 | Study of Monochromatic X-ray Mammography System | not yet recruiting | N/A | 52 | Imagine Scientific, Inc.INDUSTRY | 1 | Mar 25, 2026 | clinicaltrials |
| NCT07492043 | Breast Tumour Size Measurement by Field Cycling Imaging(BREVIA) | not yet recruiting | — | 12 | University of AberdeenOTHER | 1 | Mar 25, 2026 | clinicaltrials |
| NCT07491822 | A Single-Arm, Single-Center, Phase II Clinical Study of Camrelizumab Combined With Radiochemotherapy as Neoadjuvant Therapy for Early-Stage Triple-Negative Breast Cancer | not yet recruiting | N/A | 43 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Mar 24, 2026 | clinicaltrials |
| NCT07398118 | CRYO-1: Cryoablation in Elderly Patients With Early-Stage Breast Cancer.(CRYO-1) | not yet recruiting | N/A | 61 | St. Antonius HospitalOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT06495541 | The Real World Study of Pyrotinib in the Treatment of Advanced Breast Cancer With HER2 Positive | not yet recruiting | N/A | 500 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Mar 20, 2026 | clinicaltrials |
| NCT07484763 | Predicting Recurrence in HR+/HER2- Early Breast Cancer | not yet recruiting | — | 500 | Shengjing HospitalOTHER | 0 | Mar 20, 2026 | clinicaltrials |
| NCT07486687 | Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy(PLANET) | not yet recruiting | Phase 3 | 1,000 | The Netherlands Cancer InstituteOTHER | 0 | Mar 20, 2026 | clinicaltrials |
| NCT07483996 | Cryoablation Versus Lumpectomy in Early-Stage Breast Cancer(CRYSTAL) | not yet recruiting | Phase 3 | 938 | Franciscus Gasthuis & Vlietland (Hospital)OTHER | 0 | Mar 19, 2026 | clinicaltrials |
| NCT07478315 | IMPOWER-QoL: IMPact Of Discontinuing Premedication for WEekly Paclitaxel on bReast Cancer Patient's Quality Of Life | not yet recruiting | N/A | 50 | Charles LeMoyne HospitalOTHER | 0 | Mar 17, 2026 | clinicaltrials |
| NCT07478705 | Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Using Liquid Biopsy and Imaging(EINSTEIN-TNBC) | not yet recruiting | N/A | 30 | Sunnybrook Health Sciences CentreOTHER | 0 | Mar 17, 2026 | clinicaltrials |
| NCT07470203 | Pyrotinib Combined With Trastuzumab and Pertuzumab for Maintenance Therapy in HER2-Positive Advanced Breast Cancer | not yet recruiting | — | 42 | Peking University Cancer Hospital & InstituteOTHER | 0 | Mar 13, 2026 | clinicaltrials |
| NCT07466303 | Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer | not yet recruiting | Phase 2 | 84 | Xijing HospitalOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT07458204 | Peritumoral and Periganglionic Infiltration of Levobupivacaine Prior to Conservative Surgery for Triple-negative Breast Cancer(EPPIL) | not yet recruiting | Phase 2 | 760 | Institut Jean-GodinotOTHER | 1 | Mar 9, 2026 | clinicaltrials |
| NCT07454668 | Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases | not yet recruiting | Phase 1 | 20 | Baptist Health South FloridaOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT07428018 | Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib(VIOLET) | not yet recruiting | Phase 2 | 150 | Mario Negri Institute for Pharmacological ResearchOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT07446686 | Study on the Safety and Tolerability of Postoperative Radiotherapy Concurrent With CDK4/6 Inhibitors in HR+/HER2- High-Risk Breast Cancer | not yet recruiting | Early Phase 1 | 30 | Guizhou Provincial People's HospitalOTHER | 0 | Mar 3, 2026 | clinicaltrials |
| NCT07441486 | A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast Cancer | not yet recruiting | Phase 2 | 50 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Mar 2, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Apr 30, 2026source: clinicaltrials